© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Agreement to Acquire Boehringer
Posted 7th October 2016

Agreement to Acquire Boehringer

Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Agreement to Acquire Boehringer
Image

Eight new product lines and a fully integrated manufacturing and R&D site to transfer to Elanco, adding to its growing companion animal business; subject to FTC approval and closing of BI/Sanofi asset swap

Today Elanco U.S., Inc., a subsidiary of Eli Lilly and Company, announced an agreement to acquire Boehringer Ingelheim Vetmedica, Inc.’s (BIVI) U.S. feline, canine and rabies vaccines portfolio – as well as a fully integrated manufacturing and R&D site – for $885 million, including the estimated cost of acquired inventory. The deal will diversify Elanco’s U.S. companion animal portfolio by complementing its offerings for dogs and cats.

Joining Elanco’s U.S. portfolio – which currently includes parasiticides, pain and dermatology medicines – will be routinely administered vaccines for bordetella, Lyme disease, rabies and parvovirus, among others. Also included in the agreement are several pipeline assets.

The Fort Dodge, Iowa-based facility brings capacity to manufacture the acquired products as well as R&D and testing capabilities, including an on-site veterinary research center and lab space.

“We understand the unique bond that owners share with pets and are committed to helping those pets live longer, healthier lives,” said Jeff Simmons, president, Elanco Animal Health. “With a growing portfolio addressing both prevention and treatment of disease, Elanco can partner with veterinarians and pet caregivers to do just that.”

The acquisition is anticipated to close by early 2017, subject to approval by the Federal Trade Commission and also subject to antitrust approval and closing of Boehringer Ingelheim’s asset swap transaction with Sanofi.

The sale of BIVI’s U.S. pet vaccines business and Fort Dodge manufacturing site is a required step toward the acquisition of Merial by Boehringer Ingelheim.

The current vaccine portfolio to be acquired has experienced revenue growth over the past three years, and Lilly expects the acquisition to be accretive to GAAP earnings in 2019 and to non-GAAP earnings in 2018.

John C. Lechleiter, Ph.D., Lilly’s chairman, president and chief executive officer, said that the planned acquisition of BIVI’s U.S. feline, canine and rabies vaccines portfolio reaffirms Lilly’s confidence in Elanco’s growth potential.

“As a result of the acquisition, Elanco will bring greater value to customers by providing a suite of options for preventing common diseases in companion animals,” said Lechleiter. “Coupled with our robust food animal portfolio, this addition further strengthens Elanco’s position in the global animal health business.”

Jefferies LLC is acting as the exclusive financial advisor and Paul Hastings LLP and Paul, Weiss, Rifkind, Wharton & Garrison LLP are acting as legal advisors to Elanco and Lilly in this transaction.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
British Businesses Adopting a Zero-Waste Strategy
Corporate Social Responsibility
12/05/2022British Businesses Adopting a Zero-Waste Strategy

Here, we will list three British businesses leading the way and incorporating zero waste strategies. This includes corporations that favour sustainable waste management over zero-waste-to-landfill and waste-to-energy solutions.

Read Full PostRead - Eye Icon
Structuring a Fair Salary Scale
Finance
07/04/2020Structuring a Fair Salary Scale

Once you have decided that you need to hire a new member of staff, you need to think not only about what their role will include, but also what you will pay them. Paying a fair salary is a vital aspect of procuring the right new recruit – get it wrong and yo

Read Full PostRead - Eye Icon
Injury at Work; What to Do If You Get Hurt on the Job
News
17/06/2024Injury at Work; What to Do If You Get Hurt on the Job

Injury at Work; What to Do If You Get Hurt on the Job Suffering an injury at work can be a tough situation, not just physically but emotionally and financially too. Knowing the right steps to take after getting injured on the job is crucial to ensure you get t

Read Full PostRead - Eye Icon
How Your Business Can Work Smarter Not Harder with Software
Innovation
25/05/2023How Your Business Can Work Smarter Not Harder with Software

Running a business can be a challenging and time-consuming process. In fact, it’s incredibly easy to consider that long hours and gruelling days are the only way to achieve success. Fortunately for many, this is not the case. The latest research from Microso

Read Full PostRead - Eye Icon
Gleiss Lutz Advises Apax Partners During Acquisition of Azelis
Legal
19/05/2015Gleiss Lutz Advises Apax Partners During Acquisition of Azelis

Gleiss Lutz Advises Apax Partners During Acquisition of Azelis

Read Full PostRead - Eye Icon
Attunity Acquire Appfluent for USD18m
Finance
Read Full PostRead - Eye Icon
Growth for Drive Medical Limited
M&A
17/06/2015Growth for Drive Medical Limited

Drive Medical Limited, a leading manufacturer and distributor of durable mobility equipment in Europe, has experienced significant growth following the acquisition of two companies.

Read Full PostRead - Eye Icon
The Age of Big Data
Innovation
05/12/2016The Age of Big Data

ORTEC Consulting is a highly renowned specialist in business analytics. We support companies by providing analysts with in-depth experience in advanced analytics.

Read Full PostRead - Eye Icon
NLRB Micro-Union Decision Causes Untold Harm to Retail
Leadership
30/04/2015NLRB Micro-Union Decision Causes Untold Harm to Retail

The National Labor Relations Board’s decision to recognize a micro-union of workers in just a single department at a Macy’s store in Massachusetts rather than the entire store violates longstanding precedents on union organizing, said the NRF.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow